Jaroslaw Sroczynski

Markiewicz & Sroczynski (Cracow)
Lawyer (Partner)

Jarosław Sroczyński, Founding Partner of Markiewicz & Sroczyński, is a lawyer (graduate of the Jagiellonian University in Cracow) and an economist (graduate of the Academy of Economics in Cracow). He has 20 years experience of practice in the area of Polish and European Community competition laws. He specializes in the general areas of regulatory law, including privacy, energy and consumer laws. He advises on transactions related to licensing, distribution and franchising, etc. He also practices in unfair competition law and is developing private enforcement advice in antitrust and consumer cases.

Articles

273 Bulletin

Jaroslaw Sroczynski The President of the Office of Competition and Consumer Protection clears a merger on the LPG distribution market in Poland and imposes a set of remedies, including behavioural (Gaspol / Orlen Gaz)

121

I. The Facts On 25 July 2012 Gaspol S.A. with its seat in Warsaw (“Gaspol”) notified the President of the Office of Competition and Consumer Protection (“OCCP”) of its intention to acquire the business of bottled liquified petroleum gas (“LPG”) from Orlen Gaz Sp. z o.o. with its seat in Plock (“Orlen (...)

Jaroslaw Sroczynski The Polish competition court upholds the prohibition of a merger in the energy sector, confirms that conditions can be granted also by the court, defines when the “rule of reason” can be applicable and consequently confirms a non-primary meaning of procedural omissions of the competition authority (PGE)

81

I. The Facts Polska Grupa Energetyczna S.A. with its seat in Warsaw (“PGE”) is one of the four leading energy groups in Poland, the remaining three being Enea, Energa and Tauron. PGE intended to take control over Energa, through a conditional acquisition from the Minister of the State Treasury on (...)

Jaroslaw Sroczynski The President of the Polish Office of Competition and Consumer Protection clears a merger on the pharmaceutical market under sell-off conditions applicable to three drugs (Polpharma / Polfa)

71

I. The Facts On 26 October 2011, Polpharma S.A. with its seat in Starogard Gdanski (“Popharma”), a leading Polish producer of pharmaceutical products and active ingredients, notified the President of the Office of Competition and Consumer Protection (“OCCP”) of its intention to acquire control over (...)

Send a message